Anaplastic lymphoma kinase rearrangement prevalence in patients with advanced non-small cell lung cancer in the United States - retrospective real world data

Anaplastic Lymphoma Kinase Rearrangement

The United States ◽

Small Cell ◽

Small Cell Lung ◽

Real World Data ◽

Anaplastic Lymphoma ◽

Real-world immuno-oncology (IO) therapy treatment patterns and outcomes in patients with anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC) in the United States

Annals of Oncology ◽

10.1093/annonc/mdz063.037 ◽

2019 ◽

Vol 30 ◽

pp. ii52-ii53 ◽

Cited By ~ 1

Author(s):

X. Pan ◽

M.M. Lin ◽

Y. Yin ◽

P. Hou ◽

P. Baumann ◽

...

Keyword(s):

United States ◽

Lung Cancer ◽

Real World ◽

The United States ◽

Treatment Patterns ◽

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Therapy Treatment

P84.11 Real-World Brigatinib Dosing Patterns in Patients with Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer in the United States

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.1210 ◽

2021 ◽

Vol 16 (3) ◽

pp. S661

Author(s):

H. Lin ◽

Y. Wu ◽

M. Gorritz ◽

C. Mcguiness ◽

W. Huang ◽

...

Keyword(s):

United States ◽

Lung Cancer ◽

Small Cell Lung Cancer ◽

Real World ◽

The United States ◽

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Dosing Patterns

Cost-effectiveness of ceritinib in previously untreated anaplastic lymphoma kinase-positive metastatic non-small cell lung cancer in the United States

Journal of Medical Economics ◽

10.1080/13696998.2018.1443111 ◽

2018 ◽

Vol 21 (6) ◽

pp. 577-586 ◽

Cited By ~ 5

Author(s):

Zheng-Yi Zhou ◽

Alex Mutebi ◽

Simeng Han ◽

Arielle G. Bensimon ◽

Marie Louise Ricculli ◽

...

Keyword(s):

United States ◽

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

The United States ◽

Small Cell ◽

Small Cell Lung ◽

Diagnostic and therapeutic issues for patients with advanced non-small cell lung cancer harboring anaplastic lymphoma kinase rearrangement: European vs. US perspective (Review)

International Journal of Oncology ◽

10.3892/ijo.2014.2453 ◽

2014 ◽

Vol 45 (2) ◽

pp. 509-515 ◽

Cited By ~ 8

Author(s):

MASSIMO DI MAIO ◽

FILIPPO DE MARINIS ◽

FRED R. HIRSCH ◽

CESARE GRIDELLI

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase Rearrangement

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Real world experience on treatment, outcome and toxicity of crizotinib in patients with anaplastic lymphoma kinase positive advanced non-small cell lung cancer

Journal of Thoracic Disease ◽

10.21037/jtd.2019.09.15 ◽

2019 ◽

Vol 11 (9) ◽

pp. 3864-3873 ◽

Cited By ~ 2

Author(s):

Maria Fatima Flores Del Valle ◽

Alex Yuang-Chi Chang

Keyword(s):

Lung Cancer ◽

Treatment Outcome ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Real World ◽

Small Cell ◽

Small Cell Lung ◽

Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer Patients

Frontiers in Oncology ◽

10.3389/fonc.2020.01299 ◽

2020 ◽

Vol 10 ◽

Author(s):

Christian Britschgi ◽

Alfredo Addeo ◽

Markus Rechsteiner ◽

Raphaël Delaloye ◽

Martin Früh ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Real World ◽

Treatment Patterns ◽

Survival Outcome ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Real‐World Treatment Patterns and Progression‐Free Survival Associated with Anaplastic Lymphoma Kinase ( ALK ) Tyrosine Kinase Inhibitor Therapies for ALK + Non‐Small Cell Lung Cancer

The Oncologist ◽

10.1634/theoncologist.2020-0011 ◽

2020 ◽

Vol 25 (10) ◽

pp. 867-877 ◽

Cited By ~ 1

Author(s):

Mohammad Jahanzeb ◽

Huamao M. Lin ◽

Xiaoyun Pan ◽

Yu Yin ◽

Yanyu Wu ◽

...

Keyword(s):

Lung Cancer ◽

Real World ◽

Kinase Inhibitor ◽

Progression Free Survival ◽

Treatment Patterns ◽

Small Cell ◽

Small Cell Lung ◽

Free Survival ◽

Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer

Drug Design Development and Therapy ◽

10.2147/dddt.s91988 ◽

2015 ◽

pp. 5491

Author(s):

Baoan Chen ◽

Liting Guo ◽

Haijun Zhang ◽

Weiwei Shao

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Anaplastic Lymphoma Kinase Rearrangement ◽

Previously Treated Patients ◽

Previously Treated

Treatment Sequencing in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer in Japan: A Real-World Observational Study

Advances in Therapy ◽

10.1007/s12325-020-01392-0 ◽

2020 ◽

Vol 37 (7) ◽

pp. 3311-3323

Author(s):

Yasushi Goto ◽

Nobuyuki Yamamoto ◽

Elizabeth T. Masters ◽

Hironori Kikkawa ◽

Jack Mardekian ◽

...

Keyword(s):

Lung Cancer ◽

Observational Study ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Real World ◽

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Treatment Sequencing

Real-world progression-free survival of patients on anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) for ALK+ non-small cell lung cancer (NSCLC)

Annals of Oncology ◽

10.1093/annonc/mdy292.021 ◽

2018 ◽

Vol 29 ◽

pp. viii504

Author(s):

M. Jahanzeb ◽

H.M. Lin ◽

X. Pan ◽

Y. Yin ◽

P. Hou ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Real World ◽

Kinase Inhibitors ◽

Progression Free Survival ◽

Small Cell ◽

Small Cell Lung ◽

Free Survival ◽